study
Paolo Tarantino: Individualizing T-DXd Treatment Duration in HER2-Positive Breast Cancer
OncoDaily · 7h ago
Dana-Farber
Medicine & Biotech · covered by 10 outlets this week · tracked since 2026-10-29
Press: 10 specialist 6 independent outlet-days
Coverage
video
Radioligand Therapy for Prostate Cancer: What Patients & Care Partners Should Know
Prostate Cancer Foundation · 2d ago
RAS-Targeted Drug Offers Hope for Patient with Pancreatic Cancer
Dana-Farber Insight · 8d ago
Colorectal cancer in younger patients shows distinct cellular and gene-activity patterns
Medical Xpress · 13d ago
study
Dana-Farber Science Uncovers Differences Between Early-Onset and Average-Age-Onset Colorectal Cancer
Dana-Farber Insight · 13d ago
Physician Leaders Discuss the Future of Breast Oncology
Dana-Farber Insight · 15d ago
Couple Thriving After Innovative Treatment at Dana-Farber for Blood Cancer
Dana-Farber Insight · 20d ago
“We Agree to Disagree”: How Provider Trust Can Empower Older Adults
Dana-Farber Insight · 21d ago
study
Dana-Farber Scientists Reveal How Follicular Lymphoma Transitions to More Aggressive Disease
Dana-Farber Insight · 34d ago
How Clinical Administrative Specialists Help Patients Navigate Cancer Care
Dana-Farber Insight · 57d ago
Dana-Farber Science Backs Development of Targeted Therapy for Rare GIST Cancer
Dana-Farber Insight · 62d ago